Article Details
Retrieved on: 2021-07-02 07:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche and Novartis both get nod from medical regulators this week. The US FDA granted emergency use authorisation to Roche's Actemra to treat ...
Article found on: www.swissinfo.ch
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here